UBS Group’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
UBS Group's WGS Position: Q2 2026 in Review
UBS Group increased its GeneDx Holdings (WGS) stake by 311% in Q2 2026, buying an estimated $8.97M and bringing the position to 208,663 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3040.
UBS Group first reported a position in WGS in Q1 2021 and has held it in 18 quarters since. The position peaked at $92.5M in Q2 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- UBS Group held 208,663 shares of GeneDx Holdings worth $14.3M as of Q2 2026.
- UBS Group bought 157,838 GeneDx Holdings shares in Q2 2026, an estimated $8.97M.
- GeneDx Holdings made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3040 holding.
- UBS Group first reported a position in GeneDx Holdings in Q1 2021 and has held it in 18 quarters since.
- UBS Group's GeneDx Holdings position peaked at $92.5M in Q2 2025.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.